- Home
- LE vs ETON Comparison
LE vs ETON Comparison
Compare LE & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- ETON
- Stock Information
- Founded
- LE 1963
- ETON 2017
- Country
- LE United States
- ETON United States
- Employees
- LE N/A
- ETON N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- LE Consumer Discretionary
- ETON Health Care
- Exchange
- LE Nasdaq
- ETON Nasdaq
- Market Cap
- LE 323.8M
- ETON 329.8M
- IPO Year
- LE N/A
- ETON 2018
- Fundamental
- Price
- LE $10.68
- ETON $13.26
- Analyst Decision
- LE Strong Buy
- ETON Strong Buy
- Analyst Count
- LE 2
- ETON 3
- Target Price
- LE $20.00
- ETON $27.67
- AVG Volume (30 Days)
- LE 146.6K
- ETON 219.8K
- Earning Date
- LE 03-20-2025
- ETON 05-08-2025
- Dividend Yield
- LE N/A
- ETON N/A
- EPS Growth
- LE N/A
- ETON N/A
- EPS
- LE 0.20
- ETON N/A
- Revenue
- LE $1,362,935,000.00
- ETON $39,011,000.00
- Revenue This Year
- LE $6.31
- ETON $92.33
- Revenue Next Year
- LE N/A
- ETON $52.62
- P/E Ratio
- LE $53.48
- ETON N/A
- Revenue Growth
- LE N/A
- ETON 23.29
- 52 Week Low
- LE $9.91
- ETON $3.03
- 52 Week High
- LE $19.88
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- LE 46.54
- ETON 41.34
- Support Level
- LE $9.97
- ETON $12.24
- Resistance Level
- LE $11.05
- ETON $13.64
- Average True Range (ATR)
- LE 0.58
- ETON 0.95
- MACD
- LE 0.01
- ETON -0.14
- Stochastic Oscillator
- LE 49.04
- ETON 29.23
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.